Through the generations of Treg Products – promises, successes, and failures
Time: 12:00 pm
day: Day One AM Cell-Based Approaches
Details:
- The path from laboratory to GMP-compliant site to produce clinical-stage Tregs
- Tregs physiology matters – features of Treg product which influence safety and efficacy
- How the disease dictates the use of particular Treg products
- How to scale up? Autologous , allogeneic, CAR, TCR, antigen-specific, polyclonal or all…
